NASDAQ:XLO

Xilio Therapeutics Stock Forecast

etoro logo Buy XLO
*Your capital is at risk
$9.15
-0.0700 (-0.759%)
At Close: Jul 02, 2026
AI Analysis AI Analysis of XLO AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add XLO to Watchlist?
Some Reasons Why To Add XLO:
  • Lower volatility than the market (beta -0.09)
  • High gross margin of 70.7%
  • Highly efficient cash conversion (102% FCF/OCF ratio)
PDF

Xilio Therapeutics, Inc. stock price ended at $9.15 on Thursday, after losing 0.759%
(Updated on Jul 02, 2026)

Buy or Hold candidate since Jun 09, 2026 Gain 15.82%

The Xilio Therapeutics, Inc. stock price fell by -0.759% on the last day (Thursday, 2nd Jul 2026) from $9.22 to $9.15. During the last trading day the stock fluctuated 2.05% from a day low at $9.01 to a day high of $9.20. The price has risen in 6 of the last 10 days and is up by 4.57% over the past 2 weeks. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -6 thousand shares and in total, 16 thousand shares were bought and sold for approximately $145.69 thousand.

The stock lies in the middle of a wide and weak rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 5.21% during the next 3 months and, with a 90% probability hold a price between $8.22 and $10.10 at the end of this 3-month period.

XLO Signals & Forecast

The Xilio Therapeutics, Inc. stock holds a sell signal from the short-term Moving Average; at the same time, however, there is a buy signal from the long-term average. Since the short-term average is above the long-term average there is a general buy signal in the stock giving a positive forecast for the stock. On further gains, the stock will meet resistance from the short-term Moving Average at approximately $9.17. On a fall, the stock will find some support from the long-term average at approximately $8.48. A break-up through the short-term average will send a buy signal, whereas a breakdown through the long-term average will send a sell signal. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Tuesday, June 30, 2026, and so far it has fallen -4.49%. Further fall is indicated until a new bottom pivot has been found. Volume fell along with the price during the last trading day, which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk.

Support, Risk & Stop-loss for Xilio Therapeutics, Inc. stock

Xilio Therapeutics, Inc. finds support from accumulated volume at $8.81 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move much during the day (volatility) and with periodic low trading volume this stock is considered to be "high risk". During the last day, the stock moved $0.185 between high and low, or 2.05%. For the last week the stock has had daily average volatility of 6.32%.

Our recommended stop-loss: $8.68 (-5.16%) (This stock has high daily movements and this gives high risk. There is a sell signal from a pivot top found 2 days ago.)

Trading Expectations (XLO) For The Upcoming Trading Day Of Monday 6th

For the upcoming trading day on Monday, 6th we expect Xilio Therapeutics, Inc. to open at $9.12, and during the day (based on 14 day Average True Range), to move between $8.91 and $9.39, which gives a possible trading interval of +/-$0.473 (+/-5.31%) up or down from last closing price. If Xilio Therapeutics, Inc. takes out the full calculated possible swing range there will be an estimated 5.31% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $9.22 (0.77%) than the support at $8.81 (3.72%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Xilio Therapeutics, Inc. stock A Buy?

Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Xilio Therapeutics, Inc. stock to perform well in the short-term.

Current score: 1.842 Buy Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on July 6, 2026 - $9.12 ( 0.346%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

XLO Performance

Trading levels for XLO

StockInvest.us
Full Access. No Commitment. 7 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 9.30 1.68%
R2 9.23 0.90%
R1 9.19 0.426%
Price 9.15
S1 9.05 -1.12%
S2 9.00 -1.59%
S3 8.93 -2.37%

Accumulated Volume Support & Resistance Levels

Level Price
R3 9.58 4.70%
R2 9.27 1.31%
R1 9.22 0.765%
Price 9.15
S1 8.81 -3.72%
S2 8.75 -4.37%
S3 8.25 -9.84%

FAQ

What is the symbol for Xilio Therapeutics, Inc. Stock and on which exchange is it traded?
The symbol for Xilio Therapeutics, Inc. is XLO and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Xilio Therapeutics, Inc. Stock?
Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Xilio Therapeutics, Inc. stock to perform well in the short-term.

How to buy Xilio Therapeutics, Inc. Stock?
Xilio Therapeutics, Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Xilio Therapeutics, Inc. Stock.

What's the current price of Xilio Therapeutics, Inc. Stock?
As of the end of day on the Jul 02, 2026, the price of an Xilio Therapeutics, Inc. (XLO) share was $9.15.

What is the 52-week high and low for Xilio Therapeutics, Inc. Stock?
The 52-week high for Xilio Therapeutics, Inc. Stock is $12.74 and the 52-week low is $6.31.

What is the market capitalization of Xilio Therapeutics, Inc. Stock?
As of the Jul 02, 2026, the market capitalization of Xilio Therapeutics, Inc. is 60.163M.

When is the next earnings date for Xilio Therapeutics, Inc.?
The upcoming earnings date for Xilio Therapeutics, Inc. is Aug 13, 2026.
Click to get the best stock tips daily for free!
ABOUT XILIO THERAPEUTICS, INC.
Xilio Therapeutics
Xilio Therapeutics, Inc., a clinical-stage biotechnology company, develops immunotherapies to improve the immune system of cancer patients. Its checkpoint inhibitor program includes XTX101, a clinical-stage, tumor-selective anti-CTLA-4 mAb that is in Phase 1/2 clinical trials in patients with solid tumors. The company also develops cytokine programs, which comprises XTX202, a modified form of IL-2; XTX301, an IL-12 product candidate; and XTX401, ...
GOLDEN STAR
Ticker Change Signal Date
B
BXDC
$21.71
1.11% Jun 29
SRPT
$17.02
13.28% Jun 29
OSIS
$218.29
1.59% Jun 26
NMRK
$15.02
4.66% Jun 24
JLL
$299.78
9.23% Jun 24

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE